Natamycin Market Share, Size, Trends, Industry Analysis Report, By Form (Liquid, Powder); By Application; By Type; By Region; Segment Forecast, 2023 - 2032
Description
Natamycin Market Share, Size, Trends, Industry Analysis Report, By Form (Liquid, Powder); By Application; By Type; By Region; Segment Forecast, 2023 - 2032
The global natamycin market size is expected to reach USD 94.28 million by 2032, according to a new study by Polaris Market Research. The report “Natamycin Market Share, Size, Trends, Industry Analysis Report, By Form (Liquid, Powder); By Application; By Type; By Region; Segment Forecast, 2023 – 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The increase in demand is anticipated to be fueled by the growing global population as well as rising consumer demand for dairy and meat products. Additionally, it is anticipated that the market will grow primarily due to the expansion of the use of antifungal pharmaceutical products. For instance, in December 2019 Royal DSM, a company in the nutrition and health sectors that are committed to leading in sustainable living, acquired Royal CSK. The DSM has improved its capacity to meet the demand of the dairy industry with this acquisition.
The development of new products that use stabilizing additives to increase their stability and shelf life represents a potential market opportunity for further demand expansion. As a result of its use in a variety of industries, including medicine for the treatment of fungal infections, healthcare, & personal care again for the survival of beauty products, animal feed, poultry, & agriculture for the preservation of crops.
Additionally, the demand for natamycin is expected to rise significantly as a result of its use in numerous sectors, including agriculture, health, and personal care, animal feed, poultry, and medicine for treating fungal infections. The European Food Safety Authority is one independent organization that has approved natamycin as safe, which has increased its acceptance in the preservation industry. Together, these elements will probably increase the demand for natamycin shortly.
Natamycin Market Report Highlights
Food & Beverage Industry segment is anticipated to expand at a high CAGR. Various products include natamycin as a preservative.
The liquid segment dominated the substrate market in 2022 and is anticipated to continue dominating over the forecast period due to some factors including affordability, high shelf life, and ease of maintenance.
Asia Pacific held the largest market share and it is also anticipated to grow at the fastest rate. The population is expanding, and demand for dairy and meat products is rising, which can be attributed to this growth.
The global players include AMTECH BIOTECH Inc., Beijing Oriental Rada Corporation, Chiron Limited, Danisco Inc., DSM Corporation, Handary Group, Jiaozuo Join care Limited, Lanzhou Weiri Corp, Langfang Meihua Ltd, Pucheng Life come Ltd, Silver-Elephant Inc., and Zhengzhou New Frey
Polaris Market Research has segmented the Natamycin Market report based on form, application, type, and region:
Natamycin Market, Form Outlook (Revenue – USD Million, 2023 – 2032)
Liquid
Powder
Natamycin Market, Application Outlook (Revenue – USD Million, 2023 – 2032)
Food and Beverages
o Beverages
o Alcoholic
o Non-alcoholic
o Animal feed
o Bakery
o Confectionary
o Poultry & Seafood
o Dairy Products
o Ready Meals
o Soup and Noodles
o Snacks and Others
o Meat Products
Agriculture
Pharmaceuticals
Health and personal care
Natamycin Market, Type Outlook (Revenue – USD Million, 2023 – 2032)
Lactose
Glucose
Others
Natamycin Market, Regional Outlook (Revenue – USD Million, 2023 – 2032)
North America
U.S
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
The global natamycin market size is expected to reach USD 94.28 million by 2032, according to a new study by Polaris Market Research. The report “Natamycin Market Share, Size, Trends, Industry Analysis Report, By Form (Liquid, Powder); By Application; By Type; By Region; Segment Forecast, 2023 – 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The increase in demand is anticipated to be fueled by the growing global population as well as rising consumer demand for dairy and meat products. Additionally, it is anticipated that the market will grow primarily due to the expansion of the use of antifungal pharmaceutical products. For instance, in December 2019 Royal DSM, a company in the nutrition and health sectors that are committed to leading in sustainable living, acquired Royal CSK. The DSM has improved its capacity to meet the demand of the dairy industry with this acquisition.
The development of new products that use stabilizing additives to increase their stability and shelf life represents a potential market opportunity for further demand expansion. As a result of its use in a variety of industries, including medicine for the treatment of fungal infections, healthcare, & personal care again for the survival of beauty products, animal feed, poultry, & agriculture for the preservation of crops.
Additionally, the demand for natamycin is expected to rise significantly as a result of its use in numerous sectors, including agriculture, health, and personal care, animal feed, poultry, and medicine for treating fungal infections. The European Food Safety Authority is one independent organization that has approved natamycin as safe, which has increased its acceptance in the preservation industry. Together, these elements will probably increase the demand for natamycin shortly.
Natamycin Market Report Highlights
Food & Beverage Industry segment is anticipated to expand at a high CAGR. Various products include natamycin as a preservative.
The liquid segment dominated the substrate market in 2022 and is anticipated to continue dominating over the forecast period due to some factors including affordability, high shelf life, and ease of maintenance.
Asia Pacific held the largest market share and it is also anticipated to grow at the fastest rate. The population is expanding, and demand for dairy and meat products is rising, which can be attributed to this growth.
The global players include AMTECH BIOTECH Inc., Beijing Oriental Rada Corporation, Chiron Limited, Danisco Inc., DSM Corporation, Handary Group, Jiaozuo Join care Limited, Lanzhou Weiri Corp, Langfang Meihua Ltd, Pucheng Life come Ltd, Silver-Elephant Inc., and Zhengzhou New Frey
Polaris Market Research has segmented the Natamycin Market report based on form, application, type, and region:
Natamycin Market, Form Outlook (Revenue – USD Million, 2023 – 2032)
Liquid
Powder
Natamycin Market, Application Outlook (Revenue – USD Million, 2023 – 2032)
Food and Beverages
o Beverages
o Alcoholic
o Non-alcoholic
o Animal feed
o Bakery
o Confectionary
o Poultry & Seafood
o Dairy Products
o Ready Meals
o Soup and Noodles
o Snacks and Others
o Meat Products
Agriculture
Pharmaceuticals
Health and personal care
Natamycin Market, Type Outlook (Revenue – USD Million, 2023 – 2032)
Lactose
Glucose
Others
Natamycin Market, Regional Outlook (Revenue – USD Million, 2023 – 2032)
North America
U.S
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
117 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Natamycin Market Insights
- 4.1. Natamycin – Industry Snapshot
- 4.2. Natamycin Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising novel technology using natamycin in the agriculture sector
- 4.2.1.2. Increased demand for dairy and meat products
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Stringent Government Regulation
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Natamycin Market Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Natamycin Market, by Form
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Natamycin Market, by Form, 2019-2032 (USD Million)
- 5.3. Liquid
- 5.3.1. Global Natamycin Market, by Liquid, by Region, 2019-2032 (USD Million)
- 5.4. Powder
- 5.4.1. Global Natamycin Market, by Powder, by Region, 2019-2032 (USD Million)
- 6. Global Natamycin Market, by Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Natamycin Market, by Type, 2019-2032 (USD Million)
- 6.3. Lactose
- 6.3.1. Global Natamycin Market, by Lactose, by Region, 2019-2032 (USD Million)
- 6.4. Glucose
- 6.4.1. Global Natamycin Market, by Glucose, by Region, 2019-2032 (USD Million)
- 6.5. Others
- 6.5.1. Global Natamycin Market, by Others, by Region, 2019-2032 (USD Million)
- 7. Global Natamycin Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Natamycin Market, by Application, 2019-2032 (USD Million)
- 7.3. Food and Beverages
- 7.3.1. Global Natamycin Market, by Food and Beverages, by Region, 2019-2032 (USD Million)
- 7.3.2. Beverages
- 7.3.2.1. Global Natamycin Market, by Beverages, by Region, 2019-2032 (USD Million)
- 7.3.2.2. Alcoholic
- 7.3.2.2.1. Global Natamycin Market, by Alcoholic, by Region, 2019-2032 (USD Million)
- 7.3.2.3. Non-alcoholic
- 7.3.2.3.1. Global Natamycin Market, by Non-alcoholic, by Region, 2019-2032 (USD Million)
- 7.3.3. Animal feed
- 7.3.3.1. Global Natamycin Market, by Animal feed, by Region, 2019-2032 (USD Million)
- 7.3.4. Bakery
- 7.3.4.1. Global Natamycin Market, by Bakery, by Region, 2019-2032 (USD Million)
- 7.3.5. Confectionary
- 7.3.5.1. Global Natamycin Market, by Confectionary, by Region, 2019-2032 (USD Million)
- 7.3.6. Poultry & Seafood
- 7.3.6.1. Global Natamycin Market, by Poultry & Seafood, by Region, 2019-2032 (USD Million)
- 7.3.7. Dairy Products
- 7.3.7.1. Global Natamycin Market, by Dairy Products, by Region, 2019-2032 (USD Million)
- 7.3.8. Ready Meals
- 7.3.8.1. Global Natamycin Market, by Ready Meals, by Region, 2019-2032 (USD Million)
- 7.3.9. Soup and Noodles
- 7.3.9.1. Global Natamycin Market, by Soup and Noodles, by Region, 2019-2032 (USD Million)
- 7.3.10. Snacks and Others
- 7.3.10.1. Global Natamycin Market, by Snacks and Others, by Region, 2019-2032 (USD Million)
- 7.3.11. Meat Products
- 7.3.11.1. Global Natamycin Market, by Meat Products, by Region, 2019-2032 (USD Million)
- 7.4. Agriculture
- 7.4.1. Global Natamycin Market, by Agriculture, by Region, 2019-2032 (USD Million)
- 7.5. Pharmaceuticals
- 7.5.1. Global Natamycin Market, by Pharmaceuticals, by Region, 2019-2032 (USD Million)
- 7.6. Health and personal care
- 7.6.1. Global Natamycin Market, by Health and personal care, by Region, 2019-2032 (USD Million)
- 8. Global Natamycin Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Natamycin Market Assessment, By Geography, 2019-2032 (USD Million)
- 8.3. Natamycin Market – North America
- 8.3.1. North America: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.3.2. North America: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.3.3. North America: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.3.4. Natamycin Market – U.S.
- 8.3.4.1. U.S.: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.3.4.2. U.S.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.3.4.3. U.S.: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.3.5. Natamycin Market – Canada
- 8.3.5.1. Canada: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.3.5.2. Canada.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.3.5.3. Canada: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.4. Natamycin Market – Europe
- 8.4.1. Europe: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.4.2. Europe.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.4.3. Europe: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.4.4. Natamycin Market – UK
- 8.4.4.1. UK: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.4.4.2. UK.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.4.4.3. UK: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.4.5. Natamycin Market – France
- 8.4.5.1. France: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.4.5.2. France.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.4.5.3. France: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.4.6. Natamycin Market – Germany
- 8.4.6.1. Germany: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.4.6.2. Germany.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.4.6.3. Germany: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.4.7. Natamycin Market – Italy
- 8.4.7.1. Italy: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.4.7.2. Italy.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.4.7.3. Italy: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.4.8. Natamycin Market – Spain
- 8.4.8.1. Spain: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.4.8.2. Spain.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.4.8.3. Spain: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.4.9. Natamycin Market – Netherlands
- 8.4.9.1. Netherlands: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.4.9.2. Netherlands.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.4.9.3. Netherlands: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.4.10. Natamycin Market – Russia
- 8.4.10.1. Russia: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.4.10.2. Russia.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.4.10.3. Russia: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.5. Natamycin Market – Asia Pacific
- 8.5.1. Asia Pacific: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.5.4. Natamycin Market – China
- 8.5.4.1. China: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.5.4.2. China.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.5.4.3. China: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.5.5. Natamycin Market – India
- 8.5.5.1. India: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.5.5.2. India.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.5.5.3. India: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.5.6. Natamycin Market – Malaysia
- 8.5.6.1. Malaysia: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.5.6.2. Malaysia.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.5.6.3. Malaysia: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.5.7. Natamycin Market – Japan
- 8.5.7.1. Japan: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.5.7.2. Japan.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.5.7.3. Japan: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.5.8. Natamycin Market – Indonesia
- 8.5.8.1. Indonesia: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.5.8.2. Indonesia.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.5.8.3. Indonesia: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.5.9. Natamycin Market – South Korea
- 8.5.9.1. South Korea: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.5.9.2. South Korea.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.5.9.3. South Korea: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.6. Natamycin Market – Middle East & Africa
- 8.6.1. Middle East & Africa: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.6.4. Natamycin Market – Saudi Arabia
- 8.6.4.1. Saudi Arabia: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.6.4.2. Saudi Arabia.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.6.4.3. Saudi Arabia: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.6.5. Natamycin Market – UAE
- 8.6.5.1. UAE: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.6.5.2. UAE.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.6.5.3. UAE: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.6.6. Natamycin Market – Israel
- 8.6.6.1. Israel: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.6.6.2. Israel.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.6.6.3. Israel: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.6.7. Natamycin Market – South Africa
- 8.6.7.1. South Africa: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.6.7.2. South Africa.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.6.7.3. South Africa: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.7. Natamycin Market – Latin America
- 8.7.1. Latin America: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.7.2. Latin America.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.7.3. Latin America: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.7.4. Natamycin Market – Mexico
- 8.7.4.1. Mexico: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.7.4.2. Mexico.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.7.4.3. Mexico: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.7.5. Natamycin Market – Brazil
- 8.7.5.1. Brazil: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.7.5.2. Brazil.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.7.5.3. Brazil: Natamycin Market, by Type, 2019-2032 (USD Million)
- 8.7.6. Natamycin Market – Argentina
- 8.7.6.1. Argentina: Natamycin Market, by Form, 2019-2032 (USD Million)
- 8.7.6.2. Argentina.: Natamycin Market, by Application, 2019-2032 (USD Million)
- 8.7.6.3. Argentina: Natamycin Market, by Type, 2019-2032 (USD Million)
- 9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
- 10. Company Profiles
- 10.1. AMTECH BIOTECH Inc
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Form Benchmarking
- 10.1.4. Recent Development
- 10.2. Beijing Oriental Rada Corporation
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Form Benchmarking
- 10.2.4. Recent Development
- 10.3. Chiron Limited
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Form Benchmarking
- 10.3.4. Recent Development
- 10.4. Danisco Inc
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Form Benchmarking
- 10.4.4. Recent Development
- 10.5. DSM Corporation
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Form Benchmarking
- 10.5.4. Recent Development
- 10.6. Handary Group
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Form Benchmarking
- 10.6.4. Recent Development
- 10.7. Jiaozuo Join care Limited
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Form Benchmarking
- 10.7.4. Recent Development
- 10.8. Lanzhou Weiri Corp
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Form Benchmarking
- 10.8.4. Recent Development
- 10.9. Langfang Meihua Ltd
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Form Benchmarking
- 10.9.4. Recent Development
- 10.10. Pucheng Life come Ltd
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Form Benchmarking
- 10.10.4. Recent Development
- 10.11. Silver-Elephant Inc
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Form Benchmarking
- 10.11.4. Recent Development
- 10.12. Zhengzhou New Frey
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Form Benchmarking
- 10.12.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
